APA (7th ed.) Citation

M, N., M, H., ED, C. B., PO, B., R, H., IK, P., . . . I, G. (2026). Temelimab versus placebo in patients with post-COVID condition. Brain, behavior, and immunity, 138, 106892. https://doi.org/10.1016/j.bbi.2026.106892

Chicago Style (17th ed.) Citation

M, Nehme, et al. "Temelimab Versus Placebo in Patients with Post-COVID Condition." Brain, Behavior, and Immunity 138 (2026): 106892. https://doi.org/10.1016/j.bbi.2026.106892.

MLA (9th ed.) Citation

M, Nehme, et al. "Temelimab Versus Placebo in Patients with Post-COVID Condition." Brain, Behavior, and Immunity, vol. 138, 2026, p. 106892, https://doi.org/10.1016/j.bbi.2026.106892.